Aterian to recapitalize pharmaceutical CDMO CPL

CPL provides development, manufacturing, packaging, and testing of non-sterile liquid and semi-solid pharmaceutical prescription and regulated OTC products.

  • CPL is based in Mississauga, Ontario
  • The proposed recap is subject to the approval of the Ontario Superior Court of Justice in CPL’s and its affiliates proceedings pending under the Companies’ Creditors Arrangement Act (Canada)
  • Based in New York and Florida, Aterian invests in middle-market businesses

Aterian Investment Partners has agreed to recapitalize CPL, a Canadian pharmaceutical contract development and manufacturing organization (CDMO).

Share this